Retrobulbar optic neuritis in a bevacizumab-treated patient with metastatic breast cancer

Breast J. 2012 Sep;18(5):502-3. doi: 10.1111/j.1524-4741.2012.01293.x. Epub 2012 Aug 15.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Angiogenesis Inhibitors / adverse effects
  • Angiogenesis Inhibitors / therapeutic use*
  • Antibodies, Monoclonal, Humanized / adverse effects*
  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Bevacizumab
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / pathology*
  • Dexamethasone / therapeutic use*
  • Female
  • Humans
  • Middle Aged
  • Optic Neuritis / chemically induced*
  • Optic Neuritis / drug therapy*

Substances

  • Angiogenesis Inhibitors
  • Antibodies, Monoclonal, Humanized
  • Bevacizumab
  • Dexamethasone